Delivery Order SPE2DB22D1041-SPE2DB25FTZN6
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,028,982 units of the Typhim VI 25 mcg/0.5 mL syringe vaccine. The contract has a ceiling value of $1,368.40 and a period of performance through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,563,519,182 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a total ceiling value of $2,564.45. The contract is a firm fixed-price delivery order with a period of performance through February 2, 2024. This award is not designated as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,180,235 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The award has a ceiling value of $4,170.63 and a performance period ending on May 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4567466733 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has a ceiling value of $3,449.50 and is a firm fixed price delivery order with a completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,519.20, is for the supply of 4,568,062,424 units of the vaccine Typhim VI 25 MCG/0.5 ML SYRNG 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows AmerisourceBergen to provide a wide range of pharmaceutical...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,563,319,490 units of the TYPHIM VI 25 MCG/0.5 ML vaccine syringe. The order has a ceiling value of $9,345.95 and is a firm fixed-price contract. Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of 4,567,239,883 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The Delivery Order is valued at $28,385.00 and has a firm fixed price pricing type. The contract has a period of performance through February 12, 2025. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor, and this Delivery Order is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,342,095 units of the Typhim VI 25 MCG/0.5 ML vaccine, with a ceiling value of $17,208.40. The contract type is firm fixed price, and the ultimate completion date is June 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 25 mcg/0.5 ml syringes of the vaccine TYPHIM VI, with a firm fixed price of $3,449.50 and a performance period ending on May 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FTZN6Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,567,267,232 units of the TYPHIM VI 25 MCG/0.5 ML syringe 0.5 ML vaccine. The contract has a firm fixed-price pricing type and a ceiling value of $19,652.71. It does not have a set-aside designation, indicating open competition. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 2/13/25 |